Equity Overview
Price & Market Data
Price: $60.63
Daily Change: -$0.53 / 0.87%
Range: $59.35 - $60.91
Market Cap: $3,354,579,200
Volume: 537,266
Performance Metrics
1 Week: -3.62%
1 Month: 10.70%
3 Months: 5.22%
6 Months: -33.50%
1 Year: -9.59%
YTD: -24.70%
Company Details
Employees: 756
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.